Search Results 831-840 of 19757 for Hepatitis+C

1. A Study to Evaluate Placental Pathologies Using Ultrasound of the Human Placenta - Mayo Clinic

   Chronic, active viral infections, including HIV-1/2, HTLV-1/2, hepatitis B/C. Known autoimmune disease (e.g., rheumatoid arthritis or systemic lupus ...

2. A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis - Mayo Clinic

   ... hepatitis C virus antibody. Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or hepatitis B core antibody [HBcAb]) ...

3. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Seropositive for hepatitis C (except in the setting of a sustained virologic response [SVR], defined as aviremia at least 12 weeks after completion of antiviral ...

4. Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery - Mayo Clinic

   History of HIV, hepatitis B, or hepatitis C. Active tuberculosis or active, non-infectious pneumonitis. Evidence of interstitial lung disease. Active ...

5. Housecall: Help for dry skin as the seasons change - Mayo Clinic News Network

   Coping with side effects of hepatitis C drugs · Slideshow: Weight training exercises · HPV vaccine: Who needs it, how it works. HEALTHY RECIPES Whole-wheat ...

6. Efavirenz (oral route) - Side effects & dosage - Mayo Clinic

   Mental illness, history of—May increase the chance of having serious psychiatric side effects. Hepatitis B or; Hepatitis C or; Liver disease, mild or; QT ...

7. What may be behind the unexplained cases of hepatitis in kids - Mayo Clinic News Network

   Several countries, including the U.S., have identified or are investigating unexplained hepatitis cases in children.

8. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

   ... hepatitis B or hepatitis C or chronic liver disease are ineligible. Patients with a diagnosis of hepatitis B or C that has been treated and cleared and ...

9. Belimumab In Remission Of VASculitis - Clinical Trials

   Current or past positive test for human immunodeficiency virus (HIV), hepatitis B, or hepatitis C. History of severe allergic reaction to contrast agents or ...

10. A Study to Evaluate Docetaxel With or Without Bintrafusp Alfa to Treat Patients with Advanced Non-small Cell Lung Cancer - Mayo Clinic

    ... hepatitis B core antigen] antibody test) are eligible. Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase chain reaction ...